• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清载脂蛋白对溶栓后急性缺血性脑卒中预后的影响。

Impact of serum apolipoproteins on the prognosis of acute ischemic stroke after thrombolysis.

机构信息

Department of Neurology, Hangzhou Traditional Chinese Medicine Hospital affiliated to Zhejiang Chinese Medical University, 453# Tiyuchang Road, Hangzhou 310007, China.

Department of Neurology, Hangzhou Traditional Chinese Medicine Hospital affiliated to Zhejiang Chinese Medical University, 453# Tiyuchang Road, Hangzhou 310007, China.

出版信息

J Stroke Cerebrovasc Dis. 2024 Nov;33(11):107944. doi: 10.1016/j.jstrokecerebrovasdis.2024.107944. Epub 2024 Aug 15.

DOI:10.1016/j.jstrokecerebrovasdis.2024.107944
PMID:39153582
Abstract

OBJECTIVE

The purpose of this study is to the relationship between peripheral apolipoproteins and the prognosis of patients with acute ischemic stroke (AIS) after thrombolysis.

METHODS

A total of 231 AIS patients with thrombolysis was enrolled. Serum apolipoproteins were measured on admission after thrombolysis. All patients enrolled were followed up for 90 days. Their functional outcomes were assessed by the modified Rankin Scale (mRS). Good functional outcome was considered as mRS < 3. Logistic regression was applied to assess the association between serum apolipoproteins and the mRS at 90 days.

RESULTS

In multivariate analysis,1) ApoB (OR=0.099, 95%CI=0.017∼0.575, p=0.010) and ApoB/ApoA-1(OR=0.113, 95%CI=0.015∼0.868, p=0.036) were independent risk factors of good functional outcome at 90 days. 2). there were significant differences in the mRS score distribution at 90 days in groups according to the ROC cutoff values of ApoB (0.85g/L) and ApoB/ApoA-1 ratio (0.61) (all p<0.05).

CONCLUSION

Our findings demonstrated ApoB and ApoB/apoA-1 ratio were independent risk factors for good functional outcome at 90 days, and the ApoB level below 0.85g/L and ApoB/ApoA-1 ratio below 0.61 could be associated with a better functional outcome in this study population.

摘要

目的

本研究旨在探讨急性缺血性脑卒中(AIS)溶栓后外周载脂蛋白与患者预后的关系。

方法

共纳入 231 例接受溶栓治疗的 AIS 患者。溶栓后入院时检测血清载脂蛋白。所有入组患者均进行 90 天随访,采用改良 Rankin 量表(mRS)评估其功能结局。良好的功能结局定义为 mRS<3。采用 logistic 回归评估血清载脂蛋白与 90 天 mRS 的关系。

结果

在多变量分析中,1)ApoB(OR=0.099,95%CI=0.017∼0.575,p=0.010)和 ApoB/ApoA-1(OR=0.113,95%CI=0.015∼0.868,p=0.036)是 90 天良好功能结局的独立危险因素。2)根据 ApoB(0.85g/L)和 ApoB/ApoA-1 比值(0.61)的 ROC 截断值,90 天时 mRS 评分分布在各组间存在显著差异(均 p<0.05)。

结论

本研究结果表明,ApoB 和 ApoB/ApoA-1 比值是 90 天良好功能结局的独立危险因素,ApoB 水平低于 0.85g/L 和 ApoB/ApoA-1 比值低于 0.61 可能与该研究人群的更好功能结局相关。

相似文献

1
Impact of serum apolipoproteins on the prognosis of acute ischemic stroke after thrombolysis.血清载脂蛋白对溶栓后急性缺血性脑卒中预后的影响。
J Stroke Cerebrovasc Dis. 2024 Nov;33(11):107944. doi: 10.1016/j.jstrokecerebrovasdis.2024.107944. Epub 2024 Aug 15.
2
Mean Platelet Volume is a Prognostic Marker in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.平均血小板体积是接受静脉溶栓治疗的急性缺血性脑卒中患者的预后标志物。
J Stroke Cerebrovasc Dis. 2021 Jun;30(6):105718. doi: 10.1016/j.jstrokecerebrovasdis.2021.105718. Epub 2021 Apr 7.
3
Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial.强化血压控制与溶栓治疗急性缺血性脑卒中试验中亚洲与非亚洲溶栓患者的差异。
Cerebrovasc Dis. 2021;50(5):560-566. doi: 10.1159/000516487. Epub 2021 Jun 21.
4
Effect of post thrombolytic intracerebral hemorrhage volume on 90-day outcomes in acute ischemic stroke patients.溶栓后颅内出血体积对急性缺血性脑卒中患者 90 天结局的影响。
J Stroke Cerebrovasc Dis. 2024 Nov;33(11):107962. doi: 10.1016/j.jstrokecerebrovasdis.2024.107962. Epub 2024 Aug 25.
5
Elevated Levels of Inflammation Markers Predict Poor Outcomes in Acute Ischemic Stroke Patients After Intravenous Thrombolysis.炎症标志物水平升高预示急性缺血性脑卒中患者静脉溶栓后预后不良。
J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105587. doi: 10.1016/j.jstrokecerebrovasdis.2020.105587. Epub 2021 Jan 12.
6
Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset.多模态 MRI 引导下静脉溶栓治疗起病时间不明的脑卒中患者的结局。
Stroke Vasc Neurol. 2019 Feb 11;4(1):3-7. doi: 10.1136/svn-2018-000151. eCollection 2019 Mar.
7
Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study.二十四小时溶栓后 NIHSS 评分是急性缺血性脑卒中后最强的预后预测指标:ENCHANTED 研究。
J Am Heart Assoc. 2024 Sep 17;13(18):e036109. doi: 10.1161/JAHA.124.036109. Epub 2024 Sep 11.
8
Unlocking the potential of HB/RDW ratio as a simple marker for predicting mortality in acute ischemic stroke patients after thrombolysis.揭示 HB/RDW 比值作为溶栓后急性缺血性脑卒中患者死亡预测的简单标志物的潜力。
J Stroke Cerebrovasc Dis. 2024 Sep;33(9):107874. doi: 10.1016/j.jstrokecerebrovasdis.2024.107874. Epub 2024 Jul 14.
9
Treatment with Delipid Extracorporeal Lipoprotein Filter from Plasma after Intravenous Thrombolysis for Acute Ischemic Stroke: A Single-Center Experience.急性缺血性脑卒中静脉溶栓后使用 Delipid 体外脂蛋白过滤器从血浆中进行治疗:单中心经验。
Cerebrovasc Dis Extra. 2020;10(3):148-158. doi: 10.1159/000511050. Epub 2020 Oct 22.
10
Insulin Resistance is Significantly Related with Worse Clinical Outcomes in Non-Diabetic Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis.胰岛素抵抗与接受静脉溶栓治疗的非糖尿病急性缺血性脑卒中患者的临床结局恶化显著相关。
J Stroke Cerebrovasc Dis. 2021 Mar;30(3):105526. doi: 10.1016/j.jstrokecerebrovasdis.2020.105526. Epub 2020 Dec 16.